Experts Highlight How GLP-1s Have Revolutionized Management

The number of Americans with type 2 diabetes and/or obesity is rising, and the entry of therapies such as glucagon-like peptide-1 (GLP-1) receptor agonists has been revolutionary.

Related Keywords

United States , America , Americans , American , Helfandc Glaxosmithkline , Robert Zimmerman , Diana Isaacs , M Cecilia Lansang , Yael Mauer , Kevin Malloy , Stacey Ehrenberg , Masont Pregestational , Study Group , Astrazeneca , Health Statistics , Department Of Endocrinology At Cleveland Clinic , Department Of Endocrinology , Institute For Value , National Center , Life Sciences , American Journal , Cleveland Clinic , Hispanic Black ,